Shares of Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) were up 0.9% during trading on Tuesday . The company traded as high as €48.48 and last traded at €48.48. Approximately 1,532,797 shares changed hands during trading, The stock had previously closed at €48.04.
Bayer Aktiengesellschaft Stock Performance
The firm has a market cap of $49.58 billion, a PE ratio of -56.34, a PEG ratio of 36.39 and a beta of 0.83. The company has a debt-to-equity ratio of 129.90, a quick ratio of 0.72 and a current ratio of 1.04. The firm’s 50 day moving average price is €47.34 and its two-hundred day moving average price is €42.27.
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.
Featured Stories
- Five stocks we like better than Bayer Aktiengesellschaft
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
